⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REPL News
Replimune Group, Inc.
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
CMPX
MRK
PFE
BOLD
REPL
RDHL
RLAY
LLY
INCY
JAZZ
Replimune to Present at Two Upcoming Investor Conferences
globenewswire.com
REPL
Replimune to Present at Two Upcoming Investor Conferences
globenewswire.com
REPL
Basis Raises $100M at a $1.15B Valuation as Accounting Firms Adopt End-to-End Agents Across Accounting, Tax, and Audit
businesswire.com
GOOG
AMZN
ADBE
BOX
LPSN
OPEN
REPL
Movement's M1 Hackathon Reveals 100% AI Adoption Among Blockchain Developers
globenewswire.com
REPL
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Replimune Group, Inc. (REPL), Sable Offshore Corp. (SOC), Sarepta Therapeutics, Inc. (SRPT), and Semler Scientific, Inc. (SMLR)
globenewswire.com
SOC
SRPT
SMLR
REPL
Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
REPL
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Replimune Group, Inc. (REPL), and Fly-E Group, Inc. (FLYE)
globenewswire.com
ANRO
ATKR
REPL
FLYE
HumanX Amsterdam dévoile les 100 premiers conférenciers et invite des poids lourds mondiaux de l'IA en Europe
businesswire.com
DIS
REPL
Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
REPL